STOCKSAdam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)By Adam FeuersteinDec 19, 2014 9:02 AM EST
INVESTINGJim Cramer on the Stock Market: You Have to Love BiotechBy Jim CramerDec 3, 2014 12:29 PM EST
MARKETSEnergy Stocks Shake Off Plunging Oil Prices to Push the Dow to New HighsBy Keris Alison LahiffDec 2, 2014 4:30 PM EST
MARKETSStocks Hover Near Highs as Oil Backtracks From Monday BounceBy Keris Alison LahiffDec 2, 2014 2:23 PM EST
MARKETSStocks Gain as Construction Spending Expands, Global Stimulus Talk Heats UpBy Keris Alison LahiffDec 2, 2014 10:50 AM EST
STOCKSAvanir Fetches $3.5B From Japan's Otsuka for Reformulated Cough SyrupBy Adam FeuersteinDec 2, 2014 9:13 AM EST
MARKETSStock Futures Rise as Wall Street Recovers From Tech, Retail SelloffBy Keris Alison LahiffDec 2, 2014 9:09 AM EST
MARKETSAVANIR Pharmaceuticals (AVNR) Is Today's Pre-Market Mover With Heavy Volume StockBy Jamie HodgeDec 2, 2014 7:56 AM EST
MARKETSAvanir Pharmaceuticals (AVNR) Stock Surges Today on $3.54 Billion Otsuka DealBy Tedd CohenDec 2, 2014 7:54 AM EST
STOCKSDecember 2 Premarket Briefing: 10 Things You Should KnowBy Joseph WoelfelDec 2, 2014 6:54 AM EST
MARKETSAvanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application FeedbackBy Andrew MeolaNov 7, 2014 11:25 AM EST
MARKETSWill Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action?By Sebastian SilvaNov 4, 2014 8:52 AM EST
STOCKSSuper Important Biotech and Drug Stock Events for NovemberBy Adam FeuersteinNov 3, 2014 8:24 AM EST
MARKETSTrade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader StockBy Scott OlsonOct 30, 2014 4:19 PM EDT
STOCKSBiotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbentsBy Adam FeuersteinOct 17, 2014 7:05 AM EDT
MARKETSTrade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader StockBy Scott OlsonOct 13, 2014 4:17 PM EDT
MARKETSHow Will Public Offering Pricing Affect Avanir Pharmaceuticals (AVNR) Stock Today?By Andrew MeolaSep 24, 2014 10:10 AM EDT
MARKETSAVANIR Pharmaceuticals (AVNR) Down In Post-Market ActivityBy Marissa GoodbodySep 22, 2014 5:03 PM EDT
MARKETSInsider Trading Alert - RSG, HAL And AVNR Traded By InsidersBy Brian HamiltonSep 18, 2014 10:30 AM EDT
MARKETSAVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal TodayBy Scott OlsonSep 16, 2014 9:45 AM EDT
INVESTINGHow to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAPBy Jonas ElmerrajiSep 16, 2014 9:16 AM EDT
MARKETSWhy Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High TodayBy Andrew MeolaSep 15, 2014 4:06 PM EDT
INVESTINGAvanir's Over-Priced Cough Syrup Touted for Role in Alzheimer's AgitationBy Adam FeuersteinSep 15, 2014 10:19 AM EDT
MARKETSAVANIR Pharmaceuticals (AVNR) Is Today's Pre-Market Mover With Heavy Volume StockBy Jamie HodgeSep 15, 2014 9:00 AM EDT
